Dissecting caspase-2-mediated cell death: from intrinsic PIDDosome activation to chemical modulation

Abstract

Caspase-2, a highly conserved member of the caspase family, is considered an initiator caspase that triggers apoptosis in response to some cellular stresses. Previous studies suggest that an intracellular multi-protein complex PIDDosome, induced by genotoxic stress, serves as a platform for caspase-2 activation. Due to caspase-2’s inability to process effector caspases, however, the mechanism underlying caspase-2-mediated cell death upon PIDDosome activation remains unclear. Here, we conducted an unbiased genome-wide genetic screen and identified that the Bcl2 family protein BID is required for PIDDosome-induced, caspase-2-mediated apoptosis. PIDDosome-activated caspase-2 directly and functionally processes BID to signal the mitochondrial pathway for apoptosis induction. In addition, a designed chemical screen identified a compound, HUHS015, which specifically activates caspase-2- mediated apoptosis. HUHS015-stimulated apoptosis also requires BID but is independent of the PIDDosome. Through extensive structure–activity relationship efforts, we identified a derivative with a potency of ∼60 nmol/L in activating caspase-2-mediated apoptosis. The HUHS015-series of compounds act as efficient agonists that directly target the interdomain linker in caspase-2, representing a new mode of initiator caspase activation. Human and mouse caspase-2 differ in two crucial residues in the linker, rendering a selectivity of the agonists for human caspase-2. The caspase-2 agonists are valuable tools to explore the physiological roles of caspase-2-mediated cell death and a base for developing small-molecule drugs for relevant diseases.

Keywords

caspase-2 / PIDDosome / BID / apoptosis / chemical screen / agonist

References

[1] Ahmad M, Srinivasula SM, Wang L et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997;57:615–619.

[2] Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in periodontal disease. J Periodontol 2019;90:288–294.

[3] Beck H, Harter M, Hass B et al. Small molecules and their impact in drug discovery: a perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory. Drug Discov Today 2022;27:1560–1574.

[4] Bergeron L, Perez GI, Macdonald G et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998;12:1304–1314.

[5] Bonzon C, Bouchier-Hayes L, Pagliari LJ et al. Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell 2006;17:2150–2157.

[6] Boucher D, Blais V, Drag M et al. Molecular determinants involved in activation of caspase 7. Biosci Rep 2011;31:283–294.

[7] Bouchier-Hayes L, Green DR. Caspase-2: the orphan caspase. Cell Death Differ 2012;19:51–57.

[8] Bratton SB, Salvesen GS. Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 2010;123:3209–3214.

[9] Brown-Suedel AN, Bouchier-Hayes L. Caspase-2 substrates: to apoptosis, cell cycle control, and beyond. Front Cell Dev Biol 2020;8:610022.

[10] Burigotto M, Mattivi A, Migliorati D et al. Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26. EMBO J 2021;40:e104844.

[11] Dickens LS, Boyd RS, Jukes-Jones R et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 2012;47:291–305.

[12] Di Donato N, Jean YY, Maga AM et al. Mutations in CRADD result in reduced Caspase-2-mediated neuronal apoptosis and cause megalencephaly with a rare lissencephaly variant. Am J Hum Genet 2016;99:1117–1129.

[13] Enoksson M, Robertson JD, Gogvadze V et al. Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J Biol Chem 2004;279:49575–49578.

[14] Fava LL, Bock FJ, Geley S et al. Caspase-2 at a glance. J Cell Sci 2012;125:5911–5915.

[15] Fava LL, Schuler F, Sladky V et al. The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev 2017;31:34–45.

[16] Guo Y, Srinivasula SM, Druilhe A et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002;277:13430–13437.

[17] Ho LH, Taylor R, Dorstyn L et al. A tumor suppressor function for caspase-2. Proc Natl Acad Sci U S A 2009;106:5336–5341.

[18] Janssens S, Tinel A. The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ 2012;19:13–20.

[19] Kuida K. Caspase-9. Int J Biochem Cell Biol 2000;32:121–124.

[20] Kuida K, Haydar TF, Kuan CY et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lack-ing caspase 9. Cell 1998;94:325–337.

[21] Li H, Zhu H, Xu CJ et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491–501.

[22] Lin Y, Ma W, Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000;26:122–127.

[23] Manzl C, Peintner L, Krumschnabel G et al. PIDDosome-independent tumor suppression by Caspase-2. Cell Death Differ 2012;19:1722–1732.

[24] McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013;5:a008656.

[25] O’Reilly LA, Ekert P, Harvey N et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002;9:832–841.

[26] Park HH, Logette E, Raunser S et al. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 2007;128:533–546.

[27] Paroni G, Henderson C, Schneider C et al. Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J Biol Chem 2002;277:15147–15161.

[28] Parsons MJ, McCormick L, Janke L et al. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice. Cell Death Differ 2013;20:1174–1182.

[29] Poreba M, Rut W, Groborz K et al. Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells. Cell Death Differ 2019;26:2695–2709.

[30] Puccini J, Shalini S, Voss AK et al. Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. Proc Natl Acad Sci U S A 2013;110:19920–19925.

[31] Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 1999;13:3179–3184.

[32] Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 2014;11:783–784.

[33] Schleich K, Krammer PH, Lavrik IN. The chains of death: a new view on caspase-8 activation at the DISC. Cell Cycle 2013;12:193–194.

[34] Shalini S, Dorstyn L, Wilson C et al. Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ 2012;19:1370–1380.

[35] Sheikh TI, Vasli N, Pastore S et al. Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability. Transl Psychiatry 2021;11:1.

[36] Shi J, Zhao Y, Wang K et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015;526:660–665.

[37] Stennicke HR, Jurgensmeier JM, Shin H et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084–27090.

[38] Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004;304:843–846.

[39] Tinel A, Janssens S, Lippens S et al. Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J 2007;26:197–208.

[40] Tu S, McStay GP, Boucher LM et al. In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat Cell Biol 2006;8:72–77.

[41] Twiddy D, Cain K. Caspase-9 cleavage, do you need it? Biochem J 2007;405:e1–e2.

[42] Uctepe E, Vona B, Esen FN et al. Bi-allelic truncating variants in CASP2 underlie a neurodevelopmental disorder with lissencephaly. Eur J Hum Genet 2024;32:52–60.

[43] Upton JP, Austgen K, Nishino M et al. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol Cell Biol 2008;28:3943–3951.

[44] Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity 2019;50:1352–1364.

[45] Varfolomeev EE, Schuchmann M, Luria V et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/ApO1, and Dr3 and is lethal prenatally. Immunity 1998;9:267–276.

[46] Wagner KW, Engels IH, Deveraux QL. Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway. J Biol Chem 2004;279:35047–35052.

[47] Wang K, Sun Q, Zhong X et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell 2020;180:941–955.e20.

[48] Zaki MS, Accogli A, Mirzaa G et al. Pathogenic variants in PIDD1 lead to an autosomal recessive neurodevelopmental disorder with pachygyria and psychiatric features. Eur J Hum Genet 2021;29:1226–1234.

[49] Zhang Y, Li W, Laurent T et al. Small molecules, big roles—the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci 2012;125:5609–5620.

[50] Zheng TS, Hunot S, Kuida K et al. Caspase knockouts: matters of life and death. Cell Death Differ 1999;6:1043–1053.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.